Global Medical REIT Inc (NYSE:GMRE) declared a — dividend on Monday, September 16th, Wall Street Journal reports. Investors of record on Wednesday, September 25th will be paid a dividend of 0.20 per share on Thursday, October 10th. This represents a yield of 7.1%. The ex-dividend date of this dividend is Tuesday, September 24th.

Global Medical REIT has a payout ratio of 533.3% indicating that the company cannot currently cover its dividend with earnings alone and is relying on its balance sheet to cover its dividend payments. Research analysts expect Global Medical REIT to earn $0.84 per share next year, which means the company should continue to be able to cover its $0.80 annual dividend with an expected future payout ratio of 95.2%.

Shares of GMRE opened at $11.46 on Monday. The company has a market cap of $412.73 million, a price-to-earnings ratio of 14.69 and a beta of 0.38. Global Medical REIT has a 1-year low of $8.15 and a 1-year high of $11.77. The company’s fifty day simple moving average is $10.78 and its 200 day simple moving average is $10.47. The company has a current ratio of 0.14, a quick ratio of 0.14 and a debt-to-equity ratio of 1.13.

Global Medical REIT (NYSE:GMRE) last released its quarterly earnings data on Wednesday, August 7th. The company reported $0.03 EPS for the quarter, missing the Thomson Reuters’ consensus estimate of $0.19 by ($0.16). Global Medical REIT had a net margin of 24.11% and a return on equity of 5.91%. The company had revenue of $16.88 million during the quarter, compared to analyst estimates of $16.74 million. As a group, research analysts forecast that Global Medical REIT will post 0.74 earnings per share for the current year.

Several equities analysts have commented on the stock. Zacks Investment Research upgraded shares of Global Medical REIT from a “strong sell” rating to a “hold” rating in a report on Thursday, July 11th. TheStreet downgraded shares of Global Medical REIT from a “b” rating to a “c+” rating in a report on Thursday, August 8th. Finally, ValuEngine downgraded shares of Global Medical REIT from a “buy” rating to a “hold” rating in a report on Thursday, August 1st. Three analysts have rated the stock with a hold rating and four have issued a buy rating to the company. The company has an average rating of “Buy” and a consensus price target of $10.67.

In other Global Medical REIT news, Director Ronald Marston bought 3,000 shares of Global Medical REIT stock in a transaction dated Monday, August 26th. The stock was bought at an average price of $10.70 per share, with a total value of $32,100.00. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. 11.70% of the stock is owned by insiders.

About Global Medical REIT

Global Medical REIT, Inc engages in the acquisition of purpose-built healthcare facilities and leasing of those properties to strong healthcare systems and physician groups. The company was founded on March 18, 2011 and is headquartered in Bethesda, MD.

Further Reading: Penny Stocks

Dividend History for Global Medical REIT (NYSE:GMRE)

Receive News & Ratings for Global Medical REIT Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Global Medical REIT and related companies with MarketBeat.com's FREE daily email newsletter.